The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Outcome at 8 Years After Breast-Conserving Surgery and Radiation Therapy for Invasive Breast Cancer: Influence of Margin Status and Systemic Therapy on Local Recurrence
Abstract
PURPOSE: To examine the relationship between pathologic margin status and outcome at 8 years after breast-conserving surgery and radiation therapy. PATIENTS AND METHODS: The study population comprised 533 patients with International Union Against Cancer/American Joint Committee on Cancer clinical stage I or II breast cancer who had assessable margins, who received at least 60 Gy to the primary tumor bed, and who had more than 8 years of potential follow-up. Each margin was scored (according to the presence of invasive or in situ disease that touched the inked surgical margin) as one of the following: negative, close, focally positive, or extensively positive. Outcome at 8 years was calculated using crude rates of first site of failure. A polychotomous logistic regression analysis was performed. Median follow-up time was 127 months. RESULTS: At 8 years, patients with close margins and those with negative margins both had a rate of local recurrence (LR) of 7%. Patients with extensively positive margins had an LR rate of 27%, whereas patients with focally positive margins had an intermediate rate of LR of 14%. In the polychotomous logistic regression model, margin status and the use of systemic therapy were the only two variables that had significant effects on the risk ratio of LR to remaining alive and free of disease. Among the 45 patients with focally positive margins who received systemic therapy, the crude LR rate was 7% at 8 years (95% confidence interval, 1% to 20%). CONCLUSION: Pathologic margin status and the use of adjuvant systemic therapy are the most important factors associated with LR among patients treated with breast-conserving surgery and radiation therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fisher, B., Redmond, C., Poisson, R., Margolese, R., Wolmark, N., Wickerham, L., Fisher, E., Deutsch, M., Caplan, R., Pilch, Y., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903303201302 · Cited by 1,587
Fisher, B., Costantino, J., Redmond, C., Poisson, R., Bowman, D., Couture, J., Dimitrov, N. V., Wolmark, N., Wickerham, D. L., Fisher, E. R., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902233200802 · Cited by 1,464
Holland, R., Veling, S. H. J., Mravunac, M., & Hendriks, J. H. C. L. (1985) · Cancer · doi:10.1002/1097-0142(19850901)56:5<979::aid-cncr2820560502>3.0.co;2-n · Cited by 1,133
Schnitt, S. J., Abner, A., Gelman, R., Connolly, J. L., Recht, A., Duda, R. B., Eberlein, T. J., Mayzel, K., Silver, B., & Harris, J. R. (1994) · Cancer · doi:10.1002/1097-0142(19940915)74:6<1746::aid-cncr2820740617>3.0.co;2-y · Cited by 472
Self-citationRecht, A., Come, S. E., Henderson, I. C., Gelman, R. S., Silver, B., Hayes, D. F., Shulman, L. N., & Harris, J. R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342102 · Cited by 436
Self-citationClarke, D. H., G. Lê, M., Sarrazin, D., Lacombe, M.-J., Fontaine, F., Travagli, J.-P., May-Levin, F., Contesso, G., & Arriagada, R. (1985) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(85)90372-4 · Cited by 408
Freedman, G., Fowble, B., Hanlon, A., Nicolaou, N., Fein, D., Hoffman, J., Sigurdson, E., Boraas, M., & Goldstein, L. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00112-1 · Cited by 272
Anscher, M. S., Jones, P., Prosnitz, L. R., Blackstock, W., Hebert, M., Reddick, R., Tucker, A., Dodge, R., Leight, G., Iglehart, J. D., et al. (1993) · Annals of Surgery · doi:10.1097/00000658-199307000-00005 · Cited by 225
Improved methodology for analyzing local and distant recurrence.
Gelman, R., Gelber, R., Henderson, I. C., Coleman, C. N., & Harris, J. R. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.3.548 · Cited by 224
Self-citationWinchester, D. P., & Cox, J. D. (1998) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.48.2.83 · Cited by 133
Cited by
Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy
Singletary, S. E. (2002) · The American Journal of Surgery · doi:10.1016/s0002-9610(02)01012-7 · Cited by 612
Poggi, M. M., Danforth, D. N., Sciuto, L. C., Smith, S. L., Steinberg, S. M., Liewehr, D. J., Menard, C., Lippman, M. E., Lichter, A. S., & Altemus, R. M. (2003) · Cancer · doi:10.1002/cncr.11580 · Cited by 569
Houssami, N., Macaskill, P., Luke Marinovich, M., & Morrow, M. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3480-5 · Cited by 532
Beyond the margins: real-time detection of cancer using targeted fluorophores
Zhang, R. R., Schroeder, A. B., Grudzinski, J. J., Rosenthal, E. L., Warram, J. M., Pinchuk, A. N., Eliceiri, K. W., Kuo, J. S., & Weichert, J. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.212 · Cited by 485
Wapnir, I. L., Anderson, S. J., Mamounas, E. P., Geyer, C. E., Jeong, J.-H., Tan-Chiu, E., Fisher, B., & Wolmark, N. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3273 · Cited by 466
Molecular Subtypes and Local-Regional Control of Breast Cancer
Fragomeni, S. M., Sciallis, A., & Jeruss, J. S. (2018) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2017.08.005 · Cited by 450
In vivo Margin Assessment during Partial Mastectomy Breast Surgery Using Raman Spectroscopy
Haka, A. S., Volynskaya, Z., Gardecki, J. A., Nazemi, J., Lyons, J., Hicks, D., Fitzmaurice, M., Dasari, R. R., Crowe, J. P., & Feld, M. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2815 · Cited by 424
Houssami, N., Macaskill, P., Marinovich, M. L., Dixon, J. M., Irwig, L., Brennan, M. E., & Solin, L. J. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.043 · Cited by 406
Pleijhuis, R. G., Graafland, M., de Vries, J., Bart, J., de Jong, J. S., & van Dam, G. M. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0609-z · Cited by 361
Wildiers, H., Kunkler, I., Biganzoli, L., Fracheboud, J., Vlastos, G., Bernard-Marty, C., Hurria, A., Extermann, M., Girre, V., Brain, E., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70378-9 · Cited by 338
Local Therapy and Survival in Breast Cancer
Punglia, R. S., Morrow, M., Winer, E. P., & Harris, J. R. (2007) · New England Journal of Medicine · doi:10.1056/nejmra065241 · Cited by 317
Self-citationThe American Brachytherapy Society consensus statement for accelerated partial-breast irradiation
Shah, C., Vicini, F., Shaitelman, S. F., Hepel, J., Keisch, M., Arthur, D., Khan, A. J., Kuske, R., Patel, R., & Wazer, D. E. (2018) · Brachytherapy · doi:10.1016/j.brachy.2017.09.004 · Cited by 291
Lamberts, L. E., Koch, M., de Jong, J. S., Adams, A. L. L., Glatz, J., Kranendonk, M. E. G., Terwisscha van Scheltinga, A. G. T., Jansen, L., de Vries, J., Lub-de Hooge, M. N., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0437 · Cited by 285
Wong, T. T. W., Zhang, R., Hai, P., Zhang, C., Pleitez, M. A., Aft, R. L., Novack, D. V., & Wang, L. V. (2017) · Science Advances · doi:10.1126/sciadv.1602168 · Cited by 285
Houssami, N., & Hayes, D. F. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20028 · Cited by 267
β1 Integrin Inhibition Dramatically Enhances Radiotherapy Efficacy in Human Breast Cancer Xenografts
Park, C. C., Zhang, H. J., Yao, E. S., Park, C. J., & Bissell, M. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6390 · Cited by 220
Self-citation
Metadata
- Authors
- Park, C. C., Mitsumori, M., Nixon, A., Recht, A., Connolly, J., Gelman, R., Silver, B., Hetelekidis, S., Abner, A., Harris, J. R., & Schnitt, S. J.
- Venue
- Journal of Clinical Oncology
- Published
- 2000-04-08
- Volume
- 18
- Issue
- 8
- Pages
- 1668-1675
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2172480593
- Cited by
- 548
- References
- 12
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.